ArticlePloS one2026
HIV-1 lentivirus with VSV-G envelope: Complex N glycosylation governs shifts in aggregation and infectivity state at close to physiological pH, serum, and Ca2+ levels.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The goal of the study is to determine if the N-glycosylation on a virus affects its diffusion or solution state in different environmental conditions, and if the nature of the solution states has any consequence for the virus infectivity. HIV-1 lentivirus is frequently pseudo-typed with the envelope protein of Vesicular Stomatitis Virus, VSV-G, for gene and cell therapy applications. VSV-G proteins have complex type N-glycans. The diffusion profile of the lentivirus having VSV-G envelope proteins was monitored in different solution conditions using Dynamic Light Scattering, and inferences checked by AFM, filtration, antibody, and p24 ELISA experiments. The virus switched between one of three solution states in response to changes in its environment: (a) a self-aggregated state when serum to virus ratio was low, and Ca2+ and pH levels were below 2 mM and 7.4, respectively, (b) a dispersed state when serum to virus ratio was high, but Ca2+ and pH levels were still below 2mM and 7.4, respectively, and (c) a Ca-induced aggregated state when Ca2+ and pH levels exceeded 2mM and 7.4 respectively. The diffusion peak of the aggregated virus can be pulled out by antibodies against VSV-G or can be filtered out with attendant loss in p24 count and infectivity. The three solution states exhibited significantly different infectivity levels. Interestingly, the trigger conditions for switching the virus solution state occur at physiological levels of pH, Ca2+, and serum, implying that small deviations from the homeostatic conditions can induce large changes in virus infectivity. The ability to exist and switch between three solution states was lost when the terminal sialic acid and galactose residues on the virus envelope protein were cleaved. It appears that the complex N-glycans on a virus allow the latter to respond to deviations from homeostatic environmental conditions by switching solution states.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.